OCT 17, 2017 8:41 AM PDT

Why the Flu Vaccine Doesn't Work for Young Leukemia Patients

WRITTEN BY: Kara Marker

The influenza vaccine may not be as effective as it needs to be for young leukemia patients, who are at an especially high risk for infection while undergoing treatment. A new study from St. Jude Children’s Research Hospital, published in the Journal of Pediatrics, showed that vaccinated leukemia patients were no more protected from the virus than patients who were not vaccinated.

 

Two young girls with acute lymphocytic leukemia (ALL) receiving chemotherapy. Credit: National Cancer Institute

The flu may not seem that serious to some people, just an infection that makes a person feel miserable for a week and goes away. But for those individuals whose immune systems are weak, like elderly people, babies, and children with chronic illness, an infection with flu can be deadly.

Influenza vaccinations appeared to have no protective effect in a study of nearly 500 cancer patients who were currently undergoing treatment for acute leukemia. Of the 345 patients who received flu shots and the 144 who did not, rates of flu and “flu-like illness” were virtually the same.

Lead author Elisabeth Adderson, MD, stresses that the present study displays only preliminary data. "The annual flu shot, whose side effects are generally mild and short-lived, is still recommended for patients with acute leukemia who are being treated for their disease," she said.

Also, past studies have shown that “following vaccination, 28 to 100 percent of pediatric cancer patients developed levels of antibodies considered adequate to provide protection.”

The current study, which included flu seasons between 2011 and 2014, used a trivalent vaccine developed to vaccinate against three different flu strains. Every year, experts collect data to make their best prediction of which flu strains will be the most prominent for the upcoming flu season. Researchers confirmed that the vaccine used in the study accurately illustrated the flu strains most common during each flu season studied.

Adderson understands the results of the study as a sign that more research is needed to understand how the flu vaccine works or doesn’t work for young leukemia patients. Also, there is a call for better protection for acute leukemia patients that goes beyond vaccination. Adderson explains that good hand hygiene, avoiding crowds during flu season, and encouraging people around cancer patients to get vaccinated could all help prevent the flu. Surrounding a cancer patient with people vaccinated against the flu provides herd immunity, a phenomenon that describes the protection of an individual without receiving a vaccine just because they’re surrounded by people who won’t get sick.

Lastly, in the future, Adderson is considering looking at the different types of leukemia in the context of the flu and vaccination. Does a particular type of pediatric leukemia put patients at risk of flu even after receiving the vaccine?

Pediatric leukemia is a cancer that begins in early blood-forming cells in the bone marrow, usually in white blood cells. It is the most common cancer in children and teens.

Sources: American Cancer Society, St. Jude Children’s Research Hospital

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
AUG 31, 2019
Immunology
AUG 31, 2019
AI Not Ready To Predict Acute Kidney Injury
An international group of scientists from the U.S. and U.K. published new research in Nature about the effectiveness of AI in predicting Acute Kidney Injur...
SEP 14, 2019
Genetics & Genomics
SEP 14, 2019
DNA Construction Kit Could Drive Down Costs of Immune Therapy
Researchers at KU Leuven in Belgium have created a DNA construction kit that, when injected into muscle cells, enables sheep to produce new antibodies to f...
OCT 22, 2019
Immunology
OCT 22, 2019
Immune System Responsible for Organ Failure in Malaria
In the most severe cases of malaria, a person can experience organ failure and die. Often times, though, this is not directly due to the parasitic malaria ...
DEC 04, 2019
Neuroscience
DEC 04, 2019
Antibiotic Usage May Cause Parkinson's, Study Finds
A study from Helsinki University Hospital, Finland suggests that excessive usage of certain antibiotics may increase one’s risk of developing Parkins...
DEC 16, 2019
Drug Discovery & Development
DEC 16, 2019
Drug Targets Against The Nipah Virus
The Nipah virus, first identified in 1998 and is transmitted from pigs and bats, has resulted in a high mortality rate killing more than half of all infect...
FEB 17, 2020
Immunology
FEB 17, 2020
Another HIV vaccine attempt fizzles out
Years of work and over $100 million in study costs have been abandoned after an HIV-vaccine tested in South Africa failed to protect treated individuals ag...
Loading Comments...